CU Medical Systems, Inc.
KKRX:1154802,000.00
KRW
-50.00
(-2.44%)
ISIN
KR7115480006
Return %
Stock
S&P 500
1Y
-33.77
13.14
3Y
-52.04
80.78
5Y
-63.64
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Hyung-Soo Kim
- Full Time Employees
- 113
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Wonju South Korea
- IPO Date
- Dec 15, 2011
- Website
- cu911.com
- Similar Companies
- Business
- CU Medical Systems, Inc. is a South Korea-based medical device manufacturer engaged in the research, development, production, and distribution of emergency medical devices, bio-signal monitoring systems, and healthcare equipment. Founded in 2001 and headquartered in Wonju-si, Gangwon-do, South Korea, the company specializes in resuscitation technologies and supplies its products to emergency medical services, hospitals, public institutions, and commercial enterprises across more than 80 countries worldwide, supported by international subsidiaries and distribution networks including operations in Germany and Japan. The company's product and service portfolio includes: Automated External Defibrillators (AEDs), featuring public-access, semi-automated, and fully automated devices marketed under the proprietary iPAD brand, including the iPAD CU-SP1, iPAD CU-SP2, iPAD CU-SPR, and iPAD NF1200; Professional Defibrillator and Monitor Systems, comprising high-end multi-parameter defibrillator-monitors such as the LiFEGAIN CU-HD1 and Paramedic CU-ER series designed for ambulances, emergency departments, and hospital intensive care units; CPR Training and Simulation Equipment, including dedicated training units such as the CU-SPT and NF1200 Trainer along with hands-on CPR assistance devices; Smart Connected Healthcare and Remote Management Solutions, headlined by the iPAD-Link central management platform, which provides cloud-based real-time telemetry, operational self-test verification, battery diagnostics, and electrode pad expiration tracking; Medical Consumables and Equipment Accessories, encompassing pre-connected adult and pediatric electrode pads, high-capacity lithium battery packs, wall-mount cabinets, protective cases, and ECG cables; Maternal, Neonatal, and Diagnostic Monitoring Systems, manufactured through its consolidated medical subsidiary, comprising fetal monitors, fetal dopplers, infant incubators, infant warmers, phototherapy units, and multi-parameter vital signs patient monitors; and Medical Robotics, encompassing development initiatives in specialized surgical and therapeutic robotic platforms. In recent corporate developments, CU Medical Systems acquired a controlling 33.88% equity interest in KOSDAQ-listed diagnostic device specialist Bistos Inc. in early 2026, subsequent to which it increased its ownership stake to approximately 49% to consolidate operations and integrate Bistos's fetal and neonatal monitoring lines into its global distribution channels. The company also expanded its overseas supply partnerships, notably scaling its annual AED supply agreement with Lamico, a subsidiary of Japan's Chuetsu Group, to 10,000 units through its Japanese subsidiary JCU. To facilitate broader international market access, CU Medical Systems completed filings for European Union Medical Device Regulation (EU MDR) certification and initiated approval procedures with China's National Medical Products Administration (NMPA). In addition, the company introduced its CU Medical 2.0 corporate growth strategy focused on next-generation connected emergency devices and received international recognition, including the Red Dot Design Award, for its newly engineered defibrillator hardware.